Clinical Trial Update: Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry

View source ↗

Summary

Prospective post-market clinical registry evaluating the Zenflow Spring System for lower urinary tract symptoms due to benign prostatic hyperplasia; currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Zenflow Spring System

Snippet

Sponsor: Zenflow, Inc. | Conditions: BPH (Benign Prostatic Hyperplasia) | Status: NOT_YET_RECRUITING